Zai Lab Limited
ZLAB
$26.75
$0.622.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 427.80M | 418.33M | 398.99M | 355.75M | 322.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 427.80M | 418.33M | 398.99M | 355.75M | 322.71M |
| Cost of Revenue | 390.45M | 393.48M | 382.36M | 395.21M | 376.55M |
| Gross Profit | 37.35M | 24.85M | 16.62M | -39.46M | -53.84M |
| SG&A Expenses | 284.30M | 292.97M | 298.74M | 298.75M | 300.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 674.75M | 686.45M | 681.11M | 693.96M | 676.64M |
| Operating Income | -246.95M | -268.12M | -282.12M | -338.21M | -353.92M |
| Income Before Tax | -212.52M | -252.07M | -257.10M | -270.85M | -298.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -212.52 | -252.07 | -257.10 | -270.85 | -298.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -212.52M | -252.07M | -257.10M | -270.85M | -298.33M |
| EBIT | -246.95M | -268.12M | -282.12M | -338.21M | -353.92M |
| EBITDA | -233.85M | -255.82M | -270.26M | -326.92M | -343.59M |
| EPS Basic | -20.41 | -24.91 | -25.92 | -27.80 | -30.69 |
| Normalized Basic EPS | -1.26 | -1.48 | -1.58 | -1.73 | -1.91 |
| EPS Diluted | -20.41 | -24.91 | -25.92 | -27.80 | -30.69 |
| Normalized Diluted EPS | -1.26 | -1.48 | -1.58 | -1.73 | -1.91 |
| Average Basic Shares Outstanding | 418.13M | 406.53M | 395.76M | 390.12M | 388.82M |
| Average Diluted Shares Outstanding | 41.81M | 40.65M | 39.58M | 39.01M | 38.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |